Ivermectin-Induced Acute Psychosis in Patients Infected With COVID-19 Pneumonia

Document Type

Journal Article

Publication Date

6-1-2022

Journal

Cureus

Volume

14

Issue

6

DOI

10.7759/cureus.26141

Keywords

auditory hallucination; covid 19; covid-19 induced psychosis; ivermectin and albendazole; tactile hallucination

Abstract

Coronavirus disease 2019 (COVID-19) pneumonia is an infection of the lungs that causes severe inflammation in the lungs' alveoli. It causes alveoli to fill with fluid, blood clots, and sometimes even pus. Patients who are infected with COVID-19 pneumonia experience severe cough, shortness of breath, fever, fatigue, chest pain, night sweats, chills, loss of appetite, etc. During the initial phase of the COVID-19 pneumonia pandemic, it was thought that ivermectin might be helpful in patients infected with COVID-19 pneumonia, but this was later proven to be false due to its severe risks/side effects. Infectious Disease Society of America (IDSA) suggests against the use of ivermectin for COVID-19 pneumonia. However, some providers continue to use ivermectin as one of the treatments for patients infected with COVID-19 infection. In this case report, we will discuss ivermectin causing acute psychosis in healthy 45- and 51-year-old patients with no known history of any mental health illness.

Department

Epidemiology

Link to Full Text

Share

COinS